Cargando…
Gut–brain axis volatile organic compounds derived from breath distinguish between schizophrenia and major depressive disorder
BACKGROUND: Signatures from the metabolome and microbiome have already been introduced as candidates for diagnostic and treatment support. The aim of this study was to investigate the utility of volatile organic compounds (VOCs) from the breath for detection of schizophrenia and depression. METHODS:...
Autores principales: | Henning, Daniush, Lüno, Marian, Jiang, Carina, Meyer-Lotz, Gabriela, Hoeschen, Christoph, Frodl, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CMA Impact Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095255/ https://www.ncbi.nlm.nih.gov/pubmed/37045476 http://dx.doi.org/10.1503/jpn.220139 |
Ejemplares similares
-
Volatile Organic Compounds From Breath Differ Between Patients With Major Depression and Healthy Controls
por: Lueno, Marian, et al.
Publicado: (2022) -
Breathomics profiling of metabolic pathways affected by major depression: Possibilities and limitations
por: Gbaoui, Laila, et al.
Publicado: (2022) -
Dynamic Stability of Volatile Organic Compounds in Respiratory Air in Schizophrenic Patients and Its Potential Predicting Efficacy of TAAR Agonists
por: Held, Anna, et al.
Publicado: (2023) -
Breath measurements as volatile organic compound biomarkers.
por: Wallace, L, et al.
Publicado: (1996) -
Volatile Markers for Cancer in Exhaled Breath—Could They Be the Signature of the Gut Microbiota?
por: Bhandari, Manohar Prasad, et al.
Publicado: (2023)